英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
aceitera查看　aceitera　在百度字典中的解释百度英翻中〔查看〕
aceitera查看　aceitera　在Google字典中的解释Google英翻中〔查看〕
aceitera查看　aceitera　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • SOLIRIS® (eculizumab) Home | Patient Site
    SOLIRIS ® (eculizumab) is an FDA-approved prescription medicine used to treat adults with neuromyelitis optica spectrum disorder (NMOSD) who are anti-aquaporin-4 (AQP4) antibody positive It is not known if SOLIRIS is safe and effective in children with NMOSD
  • Eculizumab in Aquaporin-4–Positive Neuromyelitis Optica Spectrum . . .
    In this randomized, double-blind, time-to-event trial, 143 adults were randomly assigned in a 2:1 ratio to receive either intravenous eculizumab (at a dose of 900 mg weekly for the first four
  • ENSPRYNG® (satralizumab) | Neuromyelitis Optica Spectrum Disorder . . .
    ENSPRYNG is a prescription medicine used to treat neuromyelitis optica spectrum disorder (NMOSD) in adults who are aquaporin-4 (AQP4) antibody positive It is not known if ENSPRYNG is safe and effective in children
  • ENSPRYNG® (satralizumab) for NMOSD Treatment | Efficacy, Safety . . .
    ENSPRYNG® (satralizumab) is an interleukin-6 (IL-6) receptor antagonist indicated as monotherapy or with immunosuppressive therapy for the treatment of neuromyelitis optica spectrum disorder (NMOSD) See full safety for more information
  • Neuromyelitis Optica Clinical Trials - Mayo Clinic Research
    Neuromyelitis optica (NMO) is an inflammatory disease of the central nervous system that is associated with autoantibodies to aquaporin-4 Treatment options for prevention of clinical relapses of NMO include immunosuppressive medications
  • Neuromyelitis Optica Spectrum Disorder and Anti-MOG Syndromes
    Neuromyelitis optica spectrum disorder (NMOSD) and anti-myelin oligodendrocyte glycoprotein (anti-MOG) syndromes are immune-mediated inflammatory conditions of the central nervous system that frequently involve the optic nerves and the spinal cord
  • Epysqli (eculizumab - European Medicines Agency
    Epysqli is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria (PNH), a disease in which excessive breakdown of red blood cells results in various medical complications, including anaemia (low levels of red blood cells) Epysqli is a ‘biosimilar medicine’
  • What You Need to Know About AQP4, MOG, and NMOSD
    In this review, we discuss the revised diagnostic criteria for NMOSD, appraise the diagnostic significance of the AQP4-IgG and MOG-IgG tests, review evidence supporting the use of available treatments for acute episodes and long-term disease modification, and highlight key emerging immunotherapies
  • FDA approves first treatment for neuromyelitis optica spectrum disorder . . .
    The U S Food and Drug Administration today approved Soliris (eculizumab) injection for intravenous use for the treatment of neuromyelitis optica spectrum disorder (NMOSD) in adult patients
  • eculizumab - Farmacotherapeutisch Kompas
    Neuromyelitis optica-spectrumstoornis (NMOSD) bij volwassenen die positief testen voor antilichamen tegen aquaporine-4 (AQP4), met een recidiverend verloop van de ziekte Atypisch hemolytisch-uremisch syndroom (aHUS) bij volwassenen en kinderen De patiënt gedurende 1 uur na infusie controleren





中文字典-英文字典  2005-2009